Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Press Releases
More News
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth...
Yahoo! Finance: News
Prenetics Global (NASDAQ:PRE) Trading Up 1.9% - Should You Buy?
Prenetics Global (NASDAQ:PRE) Stock Price Up 1.9% - Still a Buy...
MarketBeat
What is Zacks Research's Estimate for PRE Q1 Earnings?
Prenetics Global Limited (NASDAQ:PRE - Free Report) - Stock analysts at Zacks Research issued their Q1 2026 earnings estimates for Prenetics Global in a research report issued to clients and investors on Wednesday, April 8th. Zacks Research analyst B. Sorensen forecasts that the company will post ea...
MarketBeat
Q1 Earnings Estimate for Prenetics Global Issued By Sidoti
Prenetics Global Limited (NASDAQ:PRE - Free Report) - Analysts at Sidoti reduced their Q1 2026 earnings estimates for Prenetics Global in a research note issued to investors on Monday, March 30th...
MarketBeat
Prenetics Global Conference: CEO Danny Yeung details IM8's $100M ARR surge with David Beckham
A panel at an RX3 event in Orange County brought together leaders from wellness, supplements, and beverages to discuss how they work with influencers and celebritiesand why authenticity and product performance remain central to their strategies. Executives outline brand backgrounds and growth path...
MarketBeat
Prenetics Global Conference: CEO Pivots to IM8, Targets $200M 2026 Sales and $40M Buyback
Prenetics Global (NASDAQ:PRE) co-founder and CEO Danny Yeung said the company is now centered on its IM8 supplement business after divesting non-core operations over the past 12 to 18 months...
MarketBeat
Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference
Prenetics Global (NASDAQ:PRE) CEO and co-founder Danny Yeung told investors the company delivered what he described as a breakout growth story in 2025, driven by the rapid expansion of its IM8...
MarketBeat
Lake Street Capital Initiates Coverage on Prenetics Global (NASDAQ:PRE)
Lake Street Capital assumed coverage on Prenetics Global in a research report on Monday. They issued a "buy" rating and a $29.00 target price for the company...
MarketBeat
Prenetics Global Limited (NASDAQ:PRE) Short Interest Up 41.6% in February
Prenetics Global Limited (NASDAQ:PRE - Get Free Report) was the recipient of a large growth in short interest in February. As of February 27th, there was short interest totaling 476,231 shares, a...
MarketBeat

Advertisement|Remove ads.